Interesting Endo: T Trials & T1DM Self Care
Our March list includes Testosterone Trials results, self-management in patients transitioning to adult care, and cancer mortality risk with diabetes.
Interesting T2DM: Diabetic Retinopathy & Drug News
Our February list includes a newly approved drug combo, the ADA’s position statement on diabetic retinopathy, and lifestyle intervention studies.
Interesting Endo: Fracture Risk & Type 1 Management
Our February list includes bone events with thyroid cancer, treatment comparison of Graves’ disease, and exercise recommendations for type 1 diabetes.
Interesting T2DM: Peds Obesity & AHA Guides
Our February list includes updated guidelines for pediatric obesity, American Heart Assoc. statement on meal timing & frequency, and diabetes risks.
Interesting Endo: Crohn’s Disease & Thyroid Dysfunction
Our January list includes predictions of Crohn’s disease severity, the effect of marijuana on thyroid function, and several FDA updates.
Interesting T2DM: Neuropathy Care & Oral Tx Update
Our January list includes new care guidelines for neuropathy, updates to oral medication recommendations, and long-term RYGB outcomes for adolescents.
Top 10: Endocrinology Network 2016
SGLT2 inhibitors, GLP-1 receptor agonists, insulin, and more – we’ve compiled a list of this year’s most popular articles on Endocrinology Network.
Interesting Endo: Insulin Prices & PCOS Diagnosis
Our December list includes pharmaceutical company responses to soaring insulin costs, delayed PCOS diagnosis, and dementia risk with ADT.
Interesting T2DM: Psychosocial Care & CV, DM Risk
Our December list includes new care guidelines from the ADA, a new indication for an SGLT2i, and effects of PCI on CV, DM risk.
Insulin 2016: FDA News
A roundup of insulin-related FDA news includes approved combination medications, the latest devices, and CT imaging recommendations for insulin pumps.
By clicking Accept, you agree to become a member of the UBM Medica Community.